<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>37(4)</volume><submitter>Orscelik A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The comparison of mechanical thrombectomy (MT) outcomes between patients with the hyperdense middle cerebral artery sign (HMCAS) and non-HMCAS is important to evaluate the impact of this radiological finding on treatment efficacy. This meta-analysis aimed to assess the association between HMCAS and clinical outcomes in patients undergoing thrombectomy, comparing the outcomes over non-HMCAS.&lt;h4>Methods&lt;/h4>A systematic literature search was conducted in PubMed, Ovid Embase, Google Scholar, and Cochrane Library to identify studies on MT outcomes for M1 occlusions of HMCAS over non-HMCAS. Inclusion criteria encompassed modified Rankin Scale (mRS) score, mortality, symptomatic intracranial hemorrhage (sICH), and successful recanalization. Using R software version 4.1.2, we calculated pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CI).&lt;h4>Results&lt;/h4>The meta-analysis was performed for 5 studies with 724 patients. There was no association found between presence of HMCAS and achieving mRS 0-2 (OR = 0.65, 95% CI: 0.29-1.47; &lt;i>p&lt;/i> = .544). Mortality analysis also showed no significant association with presence of HMCAS (OR = 0.78, 95% CI: 0.37-1.65; &lt;i>p&lt;/i> = .520). No significant difference in sICH risk (OR = 1.54, 95% CI: 0.24-9.66; &lt;i>p&lt;/i> = .646) was found between groups. Recanalization analysis showed a non-significant positive association (OR = 1.23, 95% CI: 0.67-2.28; &lt;i>p&lt;/i> = .501). Heterogeneity was observed in all analyses.&lt;h4>Conclusion&lt;/h4>Our findings showed that there is no statistically significant difference in mRS scores, mortality, sICH, and recanalization success rates between the HMCAS and non-HMCAS groups.</pubmed_abstract><journal>The neuroradiology journal</journal><pagination>454-461</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11366193</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Outcomes of mechanical thrombectomy in M1 occlusion patients with or without hyperdense middle cerebral artery sign: A systematic review and meta-analysis.</pubmed_title><pmcid>PMC11366193</pmcid><pubmed_authors>Zandpazandi S</pubmed_authors><pubmed_authors>Arul S</pubmed_authors><pubmed_authors>Ghozy S</pubmed_authors><pubmed_authors>Senol YC</pubmed_authors><pubmed_authors>Pakkam M</pubmed_authors><pubmed_authors>Brinjikji W</pubmed_authors><pubmed_authors>Bilgin GB</pubmed_authors><pubmed_authors>Musmar B</pubmed_authors><pubmed_authors>Kallmes DF</pubmed_authors><pubmed_authors>Orscelik A</pubmed_authors><pubmed_authors>Bilgin C</pubmed_authors><pubmed_authors>Kobeissi H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Outcomes of mechanical thrombectomy in M1 occlusion patients with or without hyperdense middle cerebral artery sign: A systematic review and meta-analysis.</name><description>&lt;h4>Background&lt;/h4>The comparison of mechanical thrombectomy (MT) outcomes between patients with the hyperdense middle cerebral artery sign (HMCAS) and non-HMCAS is important to evaluate the impact of this radiological finding on treatment efficacy. This meta-analysis aimed to assess the association between HMCAS and clinical outcomes in patients undergoing thrombectomy, comparing the outcomes over non-HMCAS.&lt;h4>Methods&lt;/h4>A systematic literature search was conducted in PubMed, Ovid Embase, Google Scholar, and Cochrane Library to identify studies on MT outcomes for M1 occlusions of HMCAS over non-HMCAS. Inclusion criteria encompassed modified Rankin Scale (mRS) score, mortality, symptomatic intracranial hemorrhage (sICH), and successful recanalization. Using R software version 4.1.2, we calculated pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CI).&lt;h4>Results&lt;/h4>The meta-analysis was performed for 5 studies with 724 patients. There was no association found between presence of HMCAS and achieving mRS 0-2 (OR = 0.65, 95% CI: 0.29-1.47; &lt;i>p&lt;/i> = .544). Mortality analysis also showed no significant association with presence of HMCAS (OR = 0.78, 95% CI: 0.37-1.65; &lt;i>p&lt;/i> = .520). No significant difference in sICH risk (OR = 1.54, 95% CI: 0.24-9.66; &lt;i>p&lt;/i> = .646) was found between groups. Recanalization analysis showed a non-significant positive association (OR = 1.23, 95% CI: 0.67-2.28; &lt;i>p&lt;/i> = .501). Heterogeneity was observed in all analyses.&lt;h4>Conclusion&lt;/h4>Our findings showed that there is no statistically significant difference in mRS scores, mortality, sICH, and recanalization success rates between the HMCAS and non-HMCAS groups.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-06-03T07:03:27.584Z</modification><creation>2025-08-18T09:54:13.717Z</creation></dates><accession>S-EPMC11366193</accession><cross_references><pubmed>38146685</pubmed><doi>10.1177/19714009231224446</doi></cross_references></HashMap>